Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , Nov. 6, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Suzanne Winter , the company's new Senior Vice President, Chief Commercial Officer.  As a material inducement to Ms.
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol , M.D., Ph.D., the company's new Chief Medical & Technology Officer. As a material inducement to Dr.
Toggle Summary Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
Attributes its 5,000 Percent Revenue Growth from FY03-FY07 to Increased CyberKnife Acceptance SUNNYVALE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), has been named to Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment and
Toggle Summary Accuray Incorporated Ranked 55th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
Company's 5,000 Percent Five-Year Revenue Growth Receives National Acclaim SUNNYVALE, Calif., Nov. 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it ranked 55th on Deloitte's 2008 Technology Fast 500, a ranking of
Toggle Summary Accuray Incorporated Named as Technology Pioneer 2008 by the World Economic Forum
SUNNYVALE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the World Economic Forum has selected Accuray as a Technology Pioneers for 2008. Technology Pioneers are companies that have been identified
Toggle Summary Accuray Incorporated Files Registration Statement for Proposed Initial Public Offering
Sunnyvale, Calif., November 13, 2006 – Accuray Incorporated (“Accuray”) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of shares of its common stock.
Toggle Summary Accuray Incorporated CFO to Present at 7th Annual Needham & Company Biotechnology & Medical Technology Conference
SUNNYVALE, Calif., June 6, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its senior vice president and chief financial officer, Robert E. McNamara is scheduled to present at the 7th
Toggle Summary Accuray Incorporated CFO Resigns
Accuray Appoints Successor SUNNYVALE, Calif. , Sept. 3, 2013 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2 , 2013.  Today, Accuray has appointed Gregory
Toggle Summary Accuray Incorporated CEO Resigns, Board Appoints Successor for Next Phase of Growth
SUNNYVALE, Calif. , Oct. 12, 2012 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Euan S. Thomson has resigned as President and Chief Executive Officer and Director of the Board.  Accuray's Board has appointed Joshua H.
Toggle Summary Accuray Incorporated Announces Updated Time of Presentation at Goldman Sachs 35th Annual Healthcare Conference 2014
SUNNYVALE, Calif. , June 9, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is now scheduled to present at the Goldman Sachs 35 th Annual Healthcare Conference in Palos Verdes on Thursday, June 12, 2014 at 11:00 a.m. ET / 8:00 a.m. PT .

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.